The United States is stockpiling medications for radiation sickness, which might be a worrying sign of the times.
On Wednesday, the US Department of Health and Human Services (HHS) announced that it would spend $290 million to secure an undisclosed quantity of Amgen's blood disorder drug Nplate, which has been approved to treat blood cell injuries caused by acute radiation syndrome (ARS) in both children and adults.-- More...
